YEM Search

Plant Summary

Plant Information

TCMBank_ID:	TCMBANKHE008047
ID:	TCMBANKHE008047
植物拉丁名:	Ruta graveolens
功能与主治:	To dispel wind, abate fever, disinhibit urine, quicken blood, resolve toxin, disperse swelling./Common cold with fever, wind-damp bone pain, infant fright wind, inhibited urination, diarrhea, mounting qi, amenorrhea, knocks and falls, heat toxin sores, eczema.
药用植物名:	臭草
药用部位:	whole herb
TCM_ID_id:	3321

植物对应的化合物

化合物ID	化合物名	别名	分子式	分子质量	Smiles

TCMBANKIN000048	chalepensin		C16H14O3	254.28 g/mol	CC(C)(C=C)C1=CC2=C(C=C3C(=C2)C=CO3)OC1=O
TCMBANKIN000472	2-undecyl acetate		C13H26O2	214.34 g/mol	CCCCCCCCCC(C)OC(=O)C
TCMBANKIN000819	Rhein diglucoside	9,10-dioxo-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyanthracene-2-carboxylic acid; AC1NT01N; rhein diglucoside		608.55	C1=CC2=C(C(=C1)OC3C(C(C(C(O3)CO)O)O)O)C(=O)C4=C(C=C(C=C4C2=O)C(=O)O)OC5C(C(C(C(O5)CO)O)O)O
TCMBANKIN003224	gravelliferone nethyl ether		C20H24O3		CC(=CCC1=C(C=C2C(=C1)C=C(C(=O)O2)C(C)(C)C=C)OC)C
TCMBANKIN003446	ribalinium		C16H20NO4+	290.33 g/mol	CC(C)(C1CC2=C(C3=C(C=CC(=C3)O)[N+](=C2O1)C)OC)O
TCMBANKIN004722	marrubiin	ZINC3881917	C20H28O4	332.4 g/mol	CC1CC2C3C(CCCC3(C1(CCC4=COC=C4)O)C)(C(=O)O2)C
TCMBANKIN005970	nonyl cyclopropane	nonylcyclopropane	C12H24	168.32 g/mol	CCCCCCCCCC1CC1
TCMBANKIN008481	Ruvoside	3-[(5R,10R,14S)-3-[(2R,3S,4R,5S,6S)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-14-hydroxy-10-(hydroxymethyl)-13-methyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one; ruvoside; AC1O3DXD	C30H46O9	550.68	[HH].CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CCC5C6=CC(=O)OC6)O)C)CO)O)OC)O
TCMBANKIN009888	6-methoxydiphyllin
TCMBANKIN010032	ribalinidine		C15H17NO4	275.3 g/mol	CC1(C(CC2=C(O1)N(C3=C(C2=O)C=C(C=C3)O)C)O)C
TCMBANKIN011261	2-[4(3,4-methylenedioxyphenyl)butyl]-4-quinolone		C20H19NO3		C1OC2=C(O1)C=C(C=C2)CCCCC3=CC(=O)C4=CC=CC=C4N3
TCMBANKIN012614	rutamarin		C21H24O5	356.4 g/mol	CC(=O)OC(C)(C)C1CC2=C(O1)C=C3C(=C2)C=C(C(=O)O3)C(C)(C)C=C
TCMBANKIN012786	2-Nonyl acetate	ANW-21203; SCHEMBL1301932; 2-nonyl acetate; InChI=1/C11H22O2/c1-4-5-6-7-8-9-10(2)13-11(3)12/h10H,4-9H2,1-3H3; AC1Q5Y8G; 14936-66-4; TC-109948; Beta-nonyl acetate; GSUGVJOUDSLEBL-UHFFFAOYSA-N; VZ21549; CTK4C6173; BG01507695; 2-nonanol, acetate; AC1L3A7N; C-07550; nonan-2-yl acetate; 2-Nonanol, 2-acetate; GSUGVJOUDSLEBL-UHFFFAOYSA-; 1-Methyloctyl acetate; Acetic Acid 2-Nonyl Ester; MFCD01321125; EINECS 239-010-7; CC-04808; Acetic Acid 1-Methyloctyl Ester; FT-0637161; ACMC-1C8Q6	C11H22O2	186.29	CCCCCCCC(C)OC(=O)C
TCMBANKIN015070	arborine		C16H14N2O	250.29 g/mol	CN1C2=CC=CC=C2C(=O)N=C1CC3=CC=CC=C3
TCMBANKIN015120	3-(1,1-dimethyl allyl) herniarin	7-Methoxy-3-(2-methylbut-3-en-2-yl)-1-benzopyran-2-one; 3-(1,1-Dimethyl allyl) herniarin; 3-(1,1-Dimethyl-2-propenyl)-7-methoxy-2H-1-benzopyran-2-one; AC1L4BBZ; 3-(1,1-Dimethylallyl)-7-methoxycoumarin; 7-methoxy-3-(2-methylbut-3-en-2-yl)chromen-2-one; 7-methoxy-3-(2-methylbut-3-en-2-yl)-2H-chromen-2-one; CTK1A5922; 3-(1,1-Dimethylallyl)herniarin; 3-(1,1-dimethyl allyl)herniarin; DTXSID70175138; 20958-63-8	C15H16O3	244.28 g/mol	CC(C)(C=C)C1=CC2=C(C=C(C=C2)OC)OC1=O
TCMBANKIN016389	gravacridonolchlorine		C19H18ClNO5	375.8 g/mol	CN1C2=CC=CC=C2C(=O)C3=C1C4=C(C=C3O)OC(C4)C(CO)(CO)Cl
TCMBANKIN016477	graveobioside a		C26H28O15	580.5 g/mol	C1C(C(C(O1)OC2C(C(C(OC2OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC(=C(C=C5)O)O)O)CO)O)O)O)(CO)O
TCMBANKIN016491	rutacridone epoxide		C19H17NO4	323.3 g/mol	CC1(CO1)C2CC3=C(O2)C=C(C4=C3N(C5=CC=CC=C5C4=O)C)O
TCMBANKIN019798	chamanetin		C22H18O5	362.4 g/mol	C1C(OC2=C(C(=CC(=C2C1=O)O)O)CC3=CC=CC=C3O)C4=CC=CC=C4
TCMBANKIN020069	falaconitine		C34H47NO10	629.7 g/mol	CCN1CC2(C(CC(C34C2C(C(C31)C5=CC(C6(CC4C5C6OC(=O)C7=CC(=C(C=C7)OC)OC)O)OC)OC)OC)O)COC
TCMBANKIN022206	isopimpinellin	4,9-Dimethoxy-furo[3,2-g]chromen-7-one; 7H-Furo(3,2-g)(1)benzopyran-7-one, 4,9-dimethoxy- (8CI); isopimpinellin ; MLS000876836; KBioSS_001104; Isopimpinellin, analytical standard; NCGC00095569-02; SR-01000778471-2; NSC 401288; BRD-K72253829-001-02-8; NCI60_003765; 5,9-dimethoxy-2H-furo[3,2-g]chromen-2-one; NSC401288; 7H-Furo[3,2-g][1]benzopyran-7-one,4,9-dimethoxy-; 4CN-1065; 5, 8-Dimethoxypsoralene; 7H-Furo[3,2-g][1]benzopyran-7-one, 4,9-dimethoxy-; SpecPlus_000154; KBio3_002204; 5,9-Dimethoxypsoralen; DFMAXQKDIGCMTL-UHFFFAOYSA-N; ST5308983; UNII-20GCF755G6; SMR000440593; BSPBio_002704; 4,9-dimethoxyfuro[3,2-g]chromen-7-one; 7H-Furo[3, 4,9-dimethoxy-; NSC217988; BRD-K72253829-001-03-6; 5,8-dimethoxypsoralen; DivK1c_006250; NSC-217988; CHEMBL140796; CHEBI:28853; Spectrum4_001442; I14-13386; SPECTRUM300012; TR-031106; Oprea1_593894; NSC-401288; InChI=1/C13H10O5/c1-15-10-7-3-4-9(14)18-12(7)13(16-2)11-8(10)5-6-17-11/h3-6H,1-2H3; SR-01000778471; C-14994; 4,9-Dimethoxy-7H-furo[3,2-g]chromen-7-one; KBio1_001194; Spectrum3_001232; Dimethylpsoralen; ZINC00314951; CCRIS 4347; Q-100529; ZB010380; KBio2_003672; 4,9-dimethoxy-7-furo[3,2-g]chromenone; HMS2270M12; 4,9-Dimethoxy-7H-furo(3,2-G) (1)benzopyran-7-one; NCGC00095569-01; KBioGR_001923; W1277; MFCD00017407; AN-45204; LS-70709; CC-29668; MEGxp0_000706; DFMAXQKDIGCMTL-UHFFFAOYSA-; ACon1_002361; 482-27-9; CTK4J0725; MolPort-000-882-064; C02162; SC-97796; CCG-38585; MCULE-5163280216; AKOS000278000; ST50308983; SDCCGMLS-0066520.P001; 7H-Furo(3,2-g)(1)benzopyran-7-one, 4,9-dimethoxy- (8CI)(9CI); BDBM50361386; Spectrum_000624; Spectrum2_000308; NSC 217988; STK368476; KBio2_001104; 20GCF755G6; Isopimpinellin (4,9-Dimethoxypsoralen); 5,9-dimethoxyfurano[3,2-g]chromen-2-one; 5,8-Dimethoxy-6,7-furanocoumarin; 4,9-Dimethoxy-7H-furo[3,2-g]chromen-7-one #; DTXSID30197457; FT-0603412; 4,9-Dimethoxy-7H-furo[3,2-g][1]benzopyran-7-one; I0861; BAS 00704724; Oprea1_132007; 4,9-Dimethoxyfuro[3,2-g]benzopyran-7-one; AC1Q6AY5; Spectrum5_000023; AC1L28ZK; Isopimpinellin; SPBio_000276; 5,8-Dimethoxypsoralene; 4,9-Dimethoxy-7-oxofuro[3,2-g]chromene; 5,8-Dimethoxypsoralen; SCHEMBL498907; AG-667/03555034; 4,9-Dimethoxy-7H-furo[3,2-g][1]benzopyran-7-one, 9CI; KBio2_006240; ZINC314951; NCGC00095569-03	C13H10O5	246.22	COC1=C2C=COC2=C(C3=C1C=CC(=O)O3)OC
TCMBANKIN022744	3-[(E,1R)-5-hydroxy-1,5-dimethyl-hex-3-enyl]-6-methyl-pyrocatechol	3-[(E,1R)-5-hydroxy-1,5-dimethylhex-3-enyl]-6-methylbenzene-1,2-diol; 3-[(E,2R)-6-hydroxy-6-methylhept-4-en-2-yl]-6-methylbenzene-1,2-diol; 3-[(E,2R)-6-hydroxy-6-methyl-hept-4-en-2-yl]-6-methyl-benzene-1,2-diol; 3-[(E,1R)-5-hydroxy-1,5-dimethyl-hex-3-enyl]-6-methyl-benzene-1,2-diol		250.37
TCMBANKIN023061	n-methylplatydesmin	(2R)-2-(1-Hydroxy-1-methylethyl)-2,3-dihydro-4-methoxy-9-methylfuro[2,3-b]quinoline-9-ium	C16H20NO3+	274.33 g/mol	CC(C)(C1CC2=C(C3=CC=CC=C3[N+](=C2O1)C)OC)O
TCMBANKIN025026	grevillol		C19H32O2	292.5 g/mol	CCCCCCCCCCCCCC1=CC(=CC(=C1)O)O
TCMBANKIN028007	rutacridone		C19H17NO3	307.3 g/mol	CC(=C)C1CC2=C(O1)C=C(C3=C2N(C4=CC=CC=C4C3=O)C)O
TCMBANKIN028076	rutarin		C20H24O10	424.4 g/mol	CC(C)(C1CC2=C(O1)C(=C3C(=C2)C=CC(=O)O3)OC4C(C(C(C(O4)CO)O)O)O)O
TCMBANKIN028123	rutalinium		C16H20NO4+	290.33 g/mol	CC1(C(CC2=C(C3=C(C=CC(=C3)O)[N+](=C2O1)C)OC)O)C
TCMBANKIN028766	1-(3,4-methylenedioxyphenyl)-1e-tetradecene		C21H32O2		CCCCCCCCCCCCC=CC1=CC2=C(C=C1)OCO2
TCMBANKIN031476	arborinine	arborinine	C16H15NO4	285.29 g/mol	CN1C2=CC=CC=C2C(=O)C3=C(C(=C(C=C31)OC)OC)O
TCMBANKIN032066	kolaflavanone		C31H24O12	588.5 g/mol	COC1=C(C=C(C=C1)C2C(C(=O)C3=C(C=C(C(=C3O2)C4C(OC5=CC(=CC(=C5C4=O)O)O)C6=CC=C(C=C6)O)O)O)O)O
TCMBANKIN034141	edulinine		C16H21NO4	291.34 g/mol	CC(C)(C(CC1=C(C2=CC=CC=C2N(C1=O)C)OC)O)O
TCMBANKIN034986	rutacultin		C16H18O4	274.31 g/mol	CC(C)(C=C)C1=CC2=CC(=C(C=C2OC1=O)OC)OC
TCMBANKIN036025	gravacridonediol monomethyl ether		C20H21NO5		CC(COC)(C1CC2=C3C(=C(C=C2O1)O)C(=O)C4=CC=CC=C4N3C)O
TCMBANKIN036500	graveoline	HMS1570G09; Graveolin; HMS2097G09; DS-19520; Prestwick2_000674; CAS-485-61-0; 2-(2H-1,3-benzodioxol-5-yl)-1-methyl-1,4-dihydroquinolin-4-one; CCG-208356; SR-01000737557; 485-61-0; 2-(1,3-Benzodioxol-5-yl)-1-methyl-4(1H)-quinolinone (graveoline); CHEMBL1371756; Prestwick1_000674; AC1L733Y; SPBio_002688; MolPort-002-511-146; 4(1H)-Quinolinone,2-(1,3-benzodioxol-5-yl)-1-methyl-; SMR000386974; 2-(1,3-benzodioxol-5-yl)-1-methylquinolin-4-one; BG00620484; MLS001048950; Prestwick_165; Oprea1_746980; Prestwick0_000674; HMS2268L04; Alkaloid from Ruta angustifolia plant; SR-01000737557-3; NSC603064; STOCK1N-10299; 2-(benzo[d][1,3]dioxol-5-yl)-1-methylquinolin-4(1H)-one; COBBNRKBTCBWQP-UHFFFAOYSA-N; KS-00000TWJ; CTK8G0098; NCGC00016465-01; C10689; NSC-603064; Prestwick3_000674; AK550206; AKOS002141814; 1-Methyl-2-(3,4-methylenedioxyphenyl)-4(1H)-quinolinone; NCGC00179443-01; BRD-K92683369-001-03-6; Graveoline; DTXSID80326593; 2-(1,3-Benzodioxol-5-yl)-1-methyl-4(1H)-quinolinone, 9CI; BSPBio_000767; 4(1H)-Quinolinone, 2-(1,3-benzodioxol-5-yl)-1-methyl-; CHEBI:5541; Foliosine; ZINC265501; MCULE-1487710181; NCGC00016465-02; BPBio1_000845	C17H13NO3	279.29 g/mol	CN1C2=CC=CC=C2C(=O)C=C1C3=CC4=C(C=C3)OCO4
TCMBANKIN036792	rhein	4,5-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-carboxylic acid; 2-Anthracenecarboxylic acid, 9,10-dihydro-4,5-dihydroxy-9,10-dioxo-; 4,5-dihydroxy-7-methyl-9,10-dioxo-anthracene-2-carboxylic acid; SBB001152; C10401; AIDS001379; CCRIS 5129; Rhein; MLS000069639; 2-Anthroic acid, 9,10-dihydro-4,5-dihydroxy-9,10-dioxo- (8CI); 4,5-DiOH-anthraquinone-2-COOH; 2-Anthroic acid, 9,10-dihydro-4,5-dihydroxy-9,10-dioxo-; ACon1_000217; 2-Anthracenecarboxylic acid, 9,10-dihydro-4,5-dihydroxy-7-methyl-9,10-dioxo-; 4,5-dihydroxy-anthraquinone-2-carboxylic acid; SMR000058210; 4,5-Dihydroxy-2-anthraquinonecarboxylic acid; 1,8-DIHYDROXY-3-CARBOXYL ANTHRAQUINONE; 4,5-dihydroxy-9,10-dioxo-2-anthracenecarboxylic acid; MEGxp0_001866; LMPK02000044; 9,10-Dihydro-4,5-dihydroxy-9,10-dioxo-2-anthracene carboxylic acid; AC1MHQNE; Rhubarb yellow; 4,5-dihydroxy-9,10-dioxoanthracene-2-carboxylic acid; 1,8-Dihydroxyanthraquinone-3-carboxylic acid; 275611_ALDRICH; NSC38629; 9,10-Dihydro-4,5-dihydroxy-9,10-dioxo-2-anthracenecarboxylic acid; 4-10-00-04088 (Beilstein Handbook Reference); EINECS 207-521-4; Chrysazin-3-carboxylic acid; NSC 38629; Rhein (1,8-dihydroxy-3-carboxyl anthraquinone); 478-43-3; Monorhein; 9,10-Dihydro-4,5-dihydroxy-9,10-dioxoanthracene-2-carboxylic acid; Cassic acid; 4,5-dihydroxy-9,10-dioxo-anthracene-2-carboxylic acid; Rheic acid; AIDS-001379; 4,5-Dihydroxyanthraquinone-2-carboxylic acid; SCHEMBL18601968; R7269_SIGMA; NCGC00023342-03; 4,5-dihydroxy-7-methyl-9,10-dioxoanthracene-2-carboxylic acid; BRN 2222155; 4,5-dihydroxy-9,10-diketo-anthracene-2-carboxylic acid	C15H10O6	286.236	c1([H])c(O[H])c(C(=O)[C@]([H])(C(O[H])=C([H])C(C(O[H])=O)=C2[H])[C@@]2([H])C3=O)c3c([H])c1[H]
TCMBANKIN037303	methylpicraquassioside a		C19H24O10	412.4 g/mol	COC1=C2C=COC2=CC(=C1CCC(=O)OC)OC3C(C(C(C(O3)CO)O)O)O
TCMBANKIN037331	Xanthyletin	xanthyletin		228.24 g/mol
TCMBANKIN039519	psoralen	ZB004095; InChI=1/C11H6O3/c12-11-2-1-7-5-8-3-4-13-9(8)6-10(7)14-11/h1-6; 5-19-04-00445 (Beilstein Handbook Reference); s4737; A-Lactone; AK105376; 6-hydroxy-5-benzofuranacrylic acid gamma-lactone; Furocoumarin; Psoralen, >=99% (HPLC); 7H-Furo[3,2-g]chromen-7-one; KB-249864; MFCD00010520; Furo[4',5':6,7]coumarin; SMR000112587; 7H-Furo[3,2-g]benzopyran-7-one; Oprea1_841692; AKOS004110987; NSC404562; AX8034569; P2077; Manaderm (TN); AN-8451; C09305; LS-70690; Psoralene; FCH917722; EINECS 200-639-7; 6-Hydroxy-5-benzofuranacrylic acid beta-lactone; KS-00000KP0; ZCCUUQDIBDJBTK-UHFFFAOYSA-N; 7-furo[3,2-g]chromenone; ZINC120283; SC-18328; AC1L1M09; HSDB 3528; 7H-Furo[3,2-g][1]benzopyran-7-one; 2-Propenoic acid, 3-(6-hydroxy-5-benzofuranyl)-, delta-lactone; API0003973; 4CN-1081; AIDS038395; PHYTOALEXIN-CMPD; FT-0603268; Ficusin; UNII-KTZ7ZCN2EX; D00VUI; Furo[3,2-g]coumarin; 3-(6-Hydroxy-5-benzofuranyl)-2-propenoic Acid ; N1332; Psorline-P; MolPort-001-741-377; D08450; MEGxp0_001172; Furo[4',7]coumarin; 66-97-7; ANW-73223; CCRIS 4343; Psoralen; Bio-0831; SCHEMBL17835; KTZ7ZCN2EX; 5-Benzofuranacrylic acid, 6-hydroxy-, delta-lactone; CTK2F4103; Furo(3,2-g)-coumarin; Furo[2'.3':7.6]coumarin; BDBM50331544; psoralen ; 2H-furo[3,2-g]chromen-2-one; CS-3756; 7H-Furo(3,2-g)(1)benzopyran-7-one; MLS001304059; NSC-404562; TNP00293; HY-N0053; 3-(6-hydroxy-5-benzofuranyl)-2-propenoic acid delta-lactone; NCGC00017351-03; 7H-Furo[3,2-g]chromen-7-one #; AIDS-038395; furano[3,2-g]chromen-2-one; P-7850; NCGC00142529-01; NCGC00017351-02; 010P520; AC-7968; RTX-010528; 7H-Furo[3,2-g][1]benzopyran-7-one, 9CI; 6-hydroxy-5-benzofuranacrylic acid delta-lactone; CHEMBL164660; 6,7-Furanocoumarin; CHEBI:27616; NSC 404562; I06-0551; 5-Benzofuranacrylic acid, 6-hydroxy-, .delta.-lactone; C-07470; Furo(4',5',6,7)coumarin; MCULE-2236160968; 2-Propenoic acid, 3-(6-hydroxy-5-benzofuranyl)-, .delta.-lactone; Psoralene (DCF); BRD-K47264279-001-01-4; pyrano[5,6-f]benzofuran-7-one; ZINC00120283; Furo(2',3',7,6)coumarin; CC-34001; Psoralen, analytical standard; DTXSID00216205; BRN 0152784; Psolaren; ST057250; ACon1_001579; HMS2267L05; 7-furo[3,2-g][1]benzopyranone; furo[3,2-g]chromen-7-one; Furo[2',3':7,6]coumarin; P8399_SIGMA; W1301; Manaderm; 7H-furo[3,2-g]chromen-7-one; Psoralen, 97%; A835599; ST24045730; AJ-11687; NCGC00017351-01	C11H6O3	186.16	C1=CC(=O)OC2=CC3=C(C=CO3)C=C21
TCMBANKIN039785	12-methoxydihydrocostus lactone		C16H22O3	262.344	COCC1C2CCC(=C)C3CCC(=C)C3C2OC1=O
TCMBANKIN040469	3,6-Epoxy-5,3',4'-trihydroxy-12',13',20'-trinor-β,β-caroten-19,11-olide
TCMBANKIN040699	Saxitoxin	BDBM190233; ZINC8552277; GTPL2625; DTXSID3074313; [(R,7aS,7bS)-2-amino-7,7-dihydroxy--imino-H,H,H,1H,5H,6H,7H,7bH-pyrrolo[1,2-c]purin--yl]methyl carbamate; SCHEMBL49687; SCHEMBL13028580; Saxitoxin in acetic acid (determination in mussel); [(3AS,4R,10AS)-2,6-DIAMINO-10,10-DIHYDROXY-1H,3AH,4H,8H,9H-PYRROLO[1,2-C]PURIN-4-YL]METHYL CARBAMATE; US9174999, Table 1, Compound 1; [(3AS,4R,10AS)-2-AMINO-10,10-DIHYDROXY-6-IMINO-3H,3AH,4H,5H,8H,9H-PYRROLO[1,2-C]PURIN-4-YL]METHYL CARBAMATE		299.29 g/mol
TCMBANKIN041262	isoimperatorin	AJ-19023; Oprea1_655950; 7H-Furo[3,2-g][1]benzopyran-7-one,4-[(3-methyl-2-buten-1-yl)oxy]-; NCGC00180809-02!4-(3-methylbut-2-enoxy)furo[3,2-g]chromen-7-one; Isoimperatorin, analytical standard; 4-[(3-methylbut-2-en-1-yl)oxy]-7h-furo[3,2-g]chromen-7-one; MCULE-5468436292; Iso-imperatorin; UNII-0ZMV066080; BDBM50242377; ZB010260; BG00617053; BRD-K40367461-001-01-0; ZINC00296185; ACN-035226; HMS2268M21; CS-5801; ACon1_000176; MLS001048978; MLS000574919; API0003033; Q-100533; Oprea1_630212; 4-(3-methylbut-2-enoxy)-7-furo[3,2-g]chromenone; Iso Imperatorin; isoimperatorin ; 4-[(3-METHYLBUT-2-EN-1-YL)OXY]FURO[3,2-G]CHROMEN-7-ONE; AN-8401; CTK4J0732; I06-0434; C16976; 7,4-[(3-methyl-2-butenyl)oxy]-7H-furo[3,2-g]-1-benzopyran-7-one; AB0019796; 7H-Furo[3,2-g][1]benzopyran-7-one, 4-((3-methyl-2-butenyl)oxy)-; AIDS-071126; SCHEMBL15090959; IGWDEVSBEKYORK-UHFFFAOYSA-N; TR-031434; 482I451; NCGC00180809-01; 482-45-1; DTXSID60197460; 7H-Furo[3,2-g][1]benzopyran-7-one, 4-[(3-methyl-2-butenyl)oxy]-; 4-((3-methylbut-2-en-1-yl)oxy)-7H-furo[3,2-g]chromen-7-one; AK-23906; Isoimperatorin; AC1Q6AY9; KS-00000NN4; MFCD00272155; 0ZMV066080; AC-8047; AX8008744; SMR000156243; CHEMBL448060; HY-N0286; CHEBI:66071; KB-294187; FT-0656369; 10-[(3-methyl-2-butenyl)oxy]-7H-furo[3,2-g][1] benzopyran-7-one; STOCK1N-27740; ZINC296185; N1746; ST24047429; 4-[(3-Methyl-2-butenyl)oxy]-7H-furo[3,2-g]chromen-7-one #; MolPort-001-740-269; 7H-Furo(3,2-g)(1)benzopyran-7-one, 4-((3-methyl-2-butenyl)oxy)-; CI0035; V0302; 7H-Furo[3,2-g][1]benzopyran-7-one,4-[(3-methyl-2-butenyl)oxy]-; AIDS071126; 4-(3-methylbut-2-enoxy)furo[3,2-g]chromen-7-one; AKOS015895143; 4-(3-Methyl-but-2-enyloxy-furo[3,2-g]chromen-7-one; MEGxp0_000090; AC1L28ZP	C17H16O3	268.307	c12c(c([H])c([H])o1)c(C([H])([H])\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])c3c(OC(=C([H])[H])C([H])=C3[H])c2O[H]
TCMBANKIN041911	Cnidioside A			368.3 g/mol
TCMBANKIN043913	psoralenol	70522-30-4; 7-hydroxy-3-(3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-6-yl)chromen-4-one; Psoralenol; AC1NSZU1; LMPK12050036	C20H18O5	338.4 g/mol	CC1(C(CC2=C(O1)C=CC(=C2)C3=COC4=C(C3=O)C=CC(=C4)O)O)C
TCMBANKIN046625	Picraquassioside A			398.4 g/mol
TCMBANKIN046706	Methylcnidioside A			382.4 g/mol
TCMBANKIN047822	Graveolinine		C18H17NO3	295.332	c1([H])c([H])c([C@@]([H])(OC([H])([H])[H])C([H])=C(c2c([H])c(OC([H])([H])O3)c3c([H])c2[H])N4C([H])([H])[H])c4c([H])c1[H]
TCMBANKIN048014	gravacridonediol		C19H19NO5	341.4 g/mol	CC(CO)(C1CC2=C(O1)C=C(C3=C2N(C4=CC=CC=C4C3=O)C)O)O
TCMBANKIN049415	3'-sinapoyl-6-feruloylsucrose		C33H40O18		COC1=CC(=CC(=C1O)OC)C=CC(=O)OC2C(C(OC2(CO)OC3C(C(C(C(O3)COC(=O)C=CC4=CC(=C(C=C4)O)OC)O)O)O)CO)O
TCMBANKIN049539	Edultin	ZINC2561231; Cnidimine; HMS2224K16; [(8S,9R)-8-(2-acetyloxypropan-2-yl)-2-oxo-8,9-dihydrofuro[2,3-h]chromen-9-yl] (Z)-2-methylbut-2-enoate; MLS000574916; [(8S,9R)-8-(1-acetoxy-1-methyl-ethyl)-2-oxo-8,9-dihydrofuro[5,4-h]chromen-9-yl] (Z)-2-methylbut-2-enoate; (Z)-2-methylbut-2-enoic acid [(8S,9R)-8-(1-acetoxy-1-methylethyl)-2-oxo-8,9-dihydrofuro[5,4-h]chromen-9-yl] ester; SMR000156218; [(8S,9R)-8-(2-acetyloxypropan-2-yl)-2-oxo-8,9-dihydrofuro[5,4-h]chromen-9-yl] (Z)-2-methylbut-2-enoate; edultin; (Z)-2-methylbut-2-enoic acid [(8S,9R)-8-(1-acetoxy-1-methyl-ethyl)-2-keto-8,9-dihydrofuro[5,4-h]chromen-9-yl] ester; (8S,9R)-8-[2-(ACETYLOXY)PROPAN-2-YL]-2-OXO-8H,9H-FURO[2,3-H]CHROMEN-9-YL (2Z)-2-METHYLBUT-2-ENOATE; CHEMBL1302068; AC1NSV18; 15591-75-0; Q-100934	C21H22O7	386.4	CC=C(C)C(=O)OC1C(OC2=C1C3=C(C=C2)C=CC(=O)O3)C(C)(C)OC(=O)C
TCMBANKIN050422	gravacridonechlorine		C19H18ClNO4	359.8 g/mol	CC(CO)(C1CC2=C(O1)C=C(C3=C2N(C4=CC=CC=C4C3=O)C)O)Cl
TCMBANKIN057939	ribitol	AKOS015915193; SCHEMBL15318; meso-xylitol; (2R,3r,4S)-pentane-1,2,3,4,5-pentol; MolPort-044-875-282; D-Xylitol; s4546; UNII-YFV05Y57M9 component HEBKCHPVOIAQTA-SCDXWVJYSA-N; 84709-28-4; BRN 1720524; Wood sugar alcohol; Xylitol, Pharmaceutical Secondary Standard; Certified Reference Material; HY-100582; Ribitol (Adonitol); AKOS015903403; Adonitol, BioXtra, >=99.0% (HPLC); 127873-EP2377841A1; Adonito; 87849-01-2; Xylitol [USAN]; 353ZQ9TVDA; bmse000129; Xylitol, Vetec(TM) reagent grade, >=99%; Xylitol, European Pharmacopoeia (EP) Reference Standard; Pentitot; N1725; HEBKCHPVOIAQTA-ZXFHETKHSA-N; Xylitol, United States Pharmacopeia (USP) Reference Standard; NSC 25283; Klinit; 1,2,3,4,5-Pentahydroxypentane; 1,2,3,4,5-PentahydroxypentaneXylite; bmse000886; Kylit; 75398-81-1; Xylitab 100; Xylitab DC; MolPort-003-934-322; DB01904; HEBKCHPVOIAQTA-NGQZWQHPSA-N; 2088-EP2377849A2; ZINC100018612; CS-2987; 7313-55-5; 4-01-00-02832 (Beilstein Handbook Reference); Tox21_201056; Adonitol, BioReagent, suitable for cell culture; Adonitrot; UNII-YFV05Y57M9 component HEBKCHPVOIAQTA-ZXFHETKHSA-N; Xylisorb 700; Adonitot; (2R,3S,4S)-Pentane-1,2,3,4,5-pentaol; LS-162656; DSSTox_RID_80046; DS-11416; BG01499408; 2088-EP2311842A2; 2088-EP2314584A1; I14-19011; DTXSID7042514; Epitope ID:114703; CHEBI:15963; SCHEMBL4250; xylitol; L-xylitol; Epitope ID:114702; 6684F574-C267-40CB-8828-12F2550E58D0; CHEBI:17151; 127873-EP2275398A1; 2088-EP2292612A2; FT-0631414; NCGC00165982-01; EINECS 201-788-0; WURCS=1.0/1,0/[h111h]; Fluorette; EC 201-788-0; 1,2,3,4,5-Pentanot; 2088-EP2292234A1; HY-N0538; A0171; HEBKCHPVOIAQTA-SCDXWVJYSA-N; (2S,4R)-pentane-1,2,3,4,5-pentol; I14-7373; ST50411707; Xylitol, >=99%; D-ribitol; QSPL 191; Xylitab 300; MolPort-003-895-940; K573; 127873-EP2374783A1; (2R,3R,4S)-Pentane-1,2,3,4,5-pentaol; (2S,4R)pentane-1,2,3,4,5-pentaol; C00379; 127873-EP2295402A2; Xylitol, analytical standard; K-9195; 87-99-0; (2R,3s,4S)-Pentane-1,2,3,4,5-pentot; Xylite; MFCD00064291; (2R,3s,4S)-pentane-1,2,3,4,5-pentol; 2088-EP2371811A2; (2R,4S)-pentane-1,2,3,4,5-pentol; SCHEMBL1924966; Xyliton; UNII-VCQ006KQ1E; Ribitol (6CI,8CI,9CI); CHEMBL3137744; 12426-00-5; WURCS=1.0/1,0/[h121h]; 2088-EP2272822A1; BRN 1720523; 5DCF4F57-E023-469A-B4F3-91E8349A6705; Xylite (sugar); 488-81-3; L-ribitol; HSDB 7967; MLS002695898; Eutrit; AC1L1NKP; RB0; bmse000062; Adonit; s2612; 2088-EP2301938A1; I14-19012; C00474; Adonitol (7CI); Xylisorb 300; CS-6043; adonitol; 84709-42-2; 1,2,3,4,5-pentanepentol; Xylitol [INN:BAN:JAN:NF]; KS-00000Y00; Ribitol, Adonite, 488-81-3; AC1Q59QK; NCGC00258609-01; DSSTox_GSID_42514; UNII-353ZQ9TVDA; CHEMBL96783; AK307743; Xylit; ZINC100014205; C5H12O5; 2088-EP2305254A1; X-7000; ZINC18068098; 37191-59-6; AK307317; Adonitol, >=99%; Adonite; MFCD00064292; CHEMBL1865120; NSC 16868; EINECS 207-685-7; meso-ribitol; 2088-EP2284162A2; DSSTox_CID_22514; 1,2,3,4,5-Pentanepentot; VCQ006KQ1E; 16277-71-7; 2088-EP2284163A2; D-Adonitol; E967; Xylitol C; Newtol; Kannit; ribitol; CCG-214167; FT-0656634; xylo-Pentitol; 2088-EP2275417A2; Xylisorb; NCGC00165982-02; CAS-87-99-0; SMR001562099; Adonitt; 28296-13-1;Xylitol;Adonitol	C5H12O5	152.15 g/mol	C(C(C(C(CO)O)O)O)O
TCMBANKIN057968	subericacid	suberic acid;LMFA01170001; NSC 25952; AIDS002602; AI3-52672; Hexamethylenedicarboxylic acid; Carboxylic acids, di-, C4-11; Suberic acid; NSC53777; C08278; 1,8-Octanedioic acid; NSC25952; 60930_FLUKA; S5200_ALDRICH; 68937-72-4; ST5307924; NCGC00164012-01; EINECS 208-010-9; 1,6-Hexanedicarboxylic acid; EINECS 273-084-1; nchembio815-comp1c; AIDS-002602; 505-48-6; Octanedioic acid;Cork acid	C8H14O4	174.19 g/mol	C(CCCC(=O)O)CCC(=O)O
TCMBANKIN058136	heliosin		C27H30O17	626.5 g/mol	C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OCC(C(=C(C(COCC(C(=C(C(CO)O)O)O)O)O)O)O)O)O)O
TCMBANKIN058265	skimmin;Skimmin (8CI)	2H-1-Benzopyran-2-one, 7-(.beta.-D-glucopyranosyloxy)-; NSC267696; NSC-267696; 7-Hydroxycoumarin-7-glucoside; UMBELLIFERONE GLUCOSIDE; 93-39-0; 7-[3,4,5-trihydroxy-6-(hydroxymethyl)-2H-3,4,5,6-tetrahydropyran-2-yloxy]chrom en-2-one; ST077080; AC1L8222; 7-{[3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL]OXY}CHROMEN-2-ONE; Coumarin, 7-(.beta.-D-glucopyranosyloxy)-; Skimmine; 7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one; Umbelliferone, .beta.-D-glucopyranoside	C15H16O8	324.28 g/mol	C1=CC(=CC2=C1C=CC(=O)O2)OC3C(C(C(C(O3)CO)O)O)O
TCMBANKIN058629	rutacarpine	rutaecarpine;rutecarpine	C18H13N3O	287.3 g/mol	C1CN2C(=NC3=CC=CC=C3C2=O)C4=C1C5=CC=CC=C5N4
TCMBANKIN058680	pabulenol	7H-Furo(3,2-g)(1)benzopyran-7-one, 4-((2-hydroxy-3-methyl-3-butenyl)oxy)-, (R)-; DTXSID60187447; MLS002472950; pabulenol ; BVMOMQJYQYBMKL-LBPRGKRZSA-N; HMS2198I04; CHEMBL1870203; R-(+)-Pangelin; 33783-80-1; SMR001397058; 4-[[(R)-2-Hydroxy-3-methyl-3-butenyl]oxy]-7H-furo[3,2-g][1]benzopyran-7-one; Pangelin; {5-[2'(R)-Hydroxy-3'-methyl-3'-butenyl-oxy]furocoumarin}; 4-[(2S)-2-hydroxy-3-methylbut-3-enoxy]furo[3,2-g]chromen-7-one; 4-[(2S)-2-hydroxy-3-methylbut-3-enoxy]-7-furo[3,2-g]chromenone; 4-[(2S)-2-hydroxy-3-methyl-but-3-enoxy]furo[3,2-g]chromen-7-one; AIDS210292; AIDS-210292; {5-[2''(R)-Hydroxy-3''-methyl-3''-butenyl-oxy]furocoumarin}	C16H14O5	286.28 g/mol	CC(=C)C(COC1=C2C=CC(=O)OC2=CC3=C1C=CO3)O
TCMBANKIN058778	gravelliferone	gravelliferone methyl ether	C19H22O3	298.4 g/mol	CC(=CCC1=C(C=C2C(=C1)C=C(C(=O)O2)C(C)(C)C=C)O)C
TCMBANKIN058840	angelin	umbelliprenin2021/11/13; 532-16-1; (E,E)-7-((3,7,11-Trimethyl-2,6,10-dodecatrienyl)oxy)-2H-1-benzopyran-2-one; ZINC02126785; 7-[(2E)-3,7,11-trimethyldodeca-2,6,10-trienoxy]coumarin; 7-(3,7,11-trimethyldodeca-2,6,10-trienoxy)coumarin; 7-[(2E)-3,7,11-trimethyldodeca-2,6,10-trienoxy]-2-chromenone; 7-(3,7,11-trimethyldodeca-2,6,10-trienoxy)-2-chromenone; 7-(3,7,11-trimethyldodeca-2,6,10-trienoxy)chromen-2-one; A1784/0075600; 7-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienoxy]coumarin; 30413-87-7; 7-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienoxy]-2-chromenone; 7-[(2E)-3,7,11-trimethyldodeca-2,6,10-trienoxy]chromen-2-one; 7-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienoxy]chromen-2-one	C24H30O3	366.5 g/mol	CC(=CCCC(=CCCC(=CCOC1=CC2=C(C=C1)C=CC(=O)O2)C)C)C
TCMBANKIN059084	Byakangelicin	(R)-9-(2,3-Dihydroxy-3-methylbutoxy)-4-methoxy-7H-furo(3,2-g)(1)benzopyran-7-one; 9-[(2S)-2,3-dihydroxy-3-methylbutoxy]-4-methoxyfuro[3,2-g]chromen-7-one; 9-[(2R)-2,3-dihydroxy-3-methylbutoxy]-4-methoxy-7-furo[3,2-g]chromenone; 9-[(2R)-2,3-dihydroxy-3-methylbutoxy]-4-methoxyfuro[3,2-g]chromen-7-one; C09141; 7H-Furo(3,2-g)(1)benzopyran-7-one, 9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy-, (R)-; 9-(2,3-Dihydroxy-3-methylbutoxy)-4-methoxy-7H-furo(3,2-g)(1)benzopyran-7-one; Byak-angelicin; Bjacangelicin; MLS000574875; Bjakangelicin; PKRPFNXROFUNDE-NSHDSACASA-N; SMR000156212; Biacangelicin; 7H-FURO(3,2-g)(1)BENZOPYRAN-7-ONE, 9-(2,3-DIHYDROXY-3-METHYLBUTOXY)-4-METHOXY-,; 9-[(2R)-2,3-dihydroxy-3-methyl-butoxy]-4-methoxy-furo[3,2-g]chromen-7-one; ZINC13380829; 482-25-7; AC1NST7W; Byankagelicine; (+)-Byakangelicin; byakangelicin; 9-(2,3-dihydroxy-2-methylbutoxy)-4-methoxy-7H-furo[3,2-g][l]benzopyran-7-one; byak-angelicin	C17H18O7	334.3 g/mol	CC(C)(C(COC1=C2C(=C(C3=C1OC(=O)C=C3)OC)C=CO2)O)O
TCMBANKIN059094	heliettin	chalepin	C19H22O4	314.4 g/mol	CC(C)(C=C)C1=CC2=CC3=C(C=C2OC1=O)OC(C3)C(C)(C)O
TCMBANKIN059100	Ammijin	27497-13-8; Ammajin; marmesinin, 7H-Furo(3,2-g)(1)benzopyran-7-one, A-d-glucopyranoside; (S)-2-(1-(beta-D-Glucopyranosyloxy)-1-methylethyl)-2,3-dihydro-7H-furo(3,2-g)(1)benzopyran-7-one; MolPort-039-338-572; 2-[(2s)-7-oxo-2,3-dihydro-7h-furo[3,2-g]chromen-2-yl]propan-2-yl ; Ammajin; ZINC31597169; AC1Q6A35; CHEBI:132401; (2S)-2-[2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl]-2,3-dihydrofuro[3,2-g]chromen-7-one; (-)-Marmesinin; 1C1VEU88IF; 495-30-7; Marmesinin; (-)-marmesin beta-D-glucoside; Ammijin; 7h-furo benzopyran-7-one,2-(1-2,3-dihydro-, -; 27497-13-8; UNII-1C1VEU88IF; AC1L50FF; 2-[(2S)-7-oxo-2,3-dihydro-7H-furo[3,2-9][1]benzopyran-2-yl]propan-2-yl beta-D-glucopyranoside; 7H-Furo(3,2-g)(1)benzopyran-7-one, 2-(1-(beta-D-glucopyranosyloxy)-1-methylethyl)-2,3-dihydro-, (S)-, 2-(1-(beta-D-glucopyranosyloxy)-1-methylethyl)-2,3-dihydro-, (S)-; (2S)-2-[1-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-ethyl]-2,3-dihydrofuro[3,2-g]chromen-7-one; (2S)-2-[1-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-ethyl]-2,3-dihydrofuro[3,2-g]chromen-7-one; (S)-2-(1-(beta-D-Glucopyranosyloxy)-1-methylethyl)-2,3-dihydro-7H-furo(3,2-g)(1)benzopyran-7-one; 495-30-7; (-)-Marmesinin; (2S)-2-[2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl]-2,3-dihydrofuro[3,2-g]chromen-7-one; (2S)-2-[1-methyl-1-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]ethyl]-2,3-dihydrofuro[3,2-g]chromen-7-one	C20H24O9	408.4	CC(C)(C1CC2=C(O1)C=C3C(=C2)C=CC(=O)O3)OC4C(C(C(C(O4)CO)O)O)O
TCMBANKIN059459	Rutalinidine		C15H17NO4	275.3 g/mol	CC1(C(CC2=C(O1)N(C3=C(C2=O)C=C(C=C3)O)C)O)C
TCMBANKIN059475	bya-kangelicol		C17H16O6	316.3 g/mol	CC1(C(O1)COC2=C3C(=C(C4=C2OC(=O)C=C4)OC)C=CO3)C
TCMBANKIN060264	rutin		C27H30O16	610.5 g/mol	CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O
TCMBANKIN060985	undecan-2-ol		C11H24O	172.31 g/mol	CCCCCCCCCC(C)O
TCMBANKIN060990	1-undecene		C11H22	154.29	CCCCCCCCCC=C
TCMBANKIN061180	undecyl alcohol		C11H24O	172.31 g/mol	CCCCCCCCCCCO
TCMBANKIN061524	kokusaginine	484-08-2; C10701; Kokusaginine; BRN 0256613; JBRXRVFXQIKPEA-UHFFFAOYSA-N; NSC103013; DTXSID60197506; AC1L1UR2; MLS000574882; Dictamnine,7-dimethoxy-; ZINC900216; Dictamnine, 6,7-dimethoxy-; NSC-103013; Furo[2,3-b]quinoline, 4,6,7-trimethoxy-; NCGC00247607-01; BDBM50098783; Furo[2, 4,6,7-trimethoxy-; FURO(2,3-b)QUINOLINE, 4,6,7-TRIMETHOXY-; CHEBI:6142; NSC 103013; CCRIS 3582; 4,6,7-Trimethoxy-furo[2,3-b]quinoline; HMS2194N12; kokusaginine ; CHEMBL278779; LS-70937; Kokusaginin; 6,7-Dimethoxydictamnine; AC-542/20643020; AC1Q4Y70; SMR000156276; MEGxp0_000038; 4,6,7-Trimethoxyfuro[2,3-b]quinoline; 4-27-00-02295 (Beilstein Handbook Reference); 4,6,7-Trimethoxyfuro[2,3-b]quinoline #; HMS3328E08	C14H13NO4	259.26 g/mol	COC1=C(C=C2C(=C1)C(=C3C=COC3=N2)OC)OC
TCMBANKIN061639	xenognosin a	xenognosin	C16H16O3	256.3 g/mol	COC1=C(C=CC(=C1)O)CC=CC2=CC=C(C=C2)O
TCMBANKIN061645	o-methylpongamol		C19H16O4	308.3 g/mol	COC1=C(C=CC2=C1C=CO2)C(=O)C=C(C3=CC=CC=C3)OC
TCMBANKIN061695	Majudin	Spectrum2_000534; 5-19-06-00004 (Beilstein Handbook Reference); 4-methoxyfuro[3,2-g]chromen-7-one; Spectrum3_000663; KBio3_001545; CCRIS 4348; KBioGR_002055; 4-methoxy-7-furo[3,2-g]chromenone; DivK1c_000529; NCGC00091582-01; 7H-Furo[3,2-g][1]benzopyran-7-one, 4-methoxy-; KBio2_001274; TNP00299; NINDS_000529; Bergapten; Spectrum5_000155; EINECS 207-604-5; KBio1_000529; 4-Methoxy-7H-furo(3,2-g)(1)benzopyran-7-one; KBioSS_001274; ACon0_000984; AIDS031096; 4-methoxy-7H-furo[3,2-g]chromen-7-one; HSDB 3466; 5-Methoxypsoralen; Spectrum_000794; KBio2_003842; BSPBio_002325; MEGxp0_000990; 65320_FLUKA; BRN 0019560; 5-Mop; 6-Hydroxy-4-methoxy-5-benzofuranacrylic acid, gamma-lactone; NCGC00091582-02; Bergaptene; 5-Methoxy psoralen; NCI60_042121; 5-Methoxy-6,7-furanocoumarin; KBio2_006410; 4-Methoxy-furo[3,2-g]chromen-7-one; IDI1_000529; Bergapten(e); BAS 00674110; ACon1_001979; SPBio_000547; 5-Methoxypsoralen with ultraviolet A therapy; BERGAPTAN; Psoraderm; SDCCGMLS-0066492.P001; NSC95437; 7H-Furo(3,2-g)(1)benzopyran-7-one, 4-methoxy-; ST057259; ZINC00057731; InChI=1/C12H8O4/c1-14-12-7-2-3-11(13)16-10(7)6-9-8(12)4-5-15-9/h2-6H,1H; C01557; Heraclin; NCGC00091582-03; 4-Methoxyfuro[3,2-g]benzopyrane-7-one; 275727_ALDRICH; Spectrum4_001478; SPECTRUM300546; O-Methylbergaptol; 5-Methoxyfuranocoumarin; NSC 95437; NCGC00017357-01; AIDS-031096; 484-20-8; Oprea1_562364; 5-methoxypsoralen; bergapten;5-19-06-00004 (Beilstein Handbook Reference); AB00052148_06; V0122; DivK1c_000529; NCGC00259906-01; KBio2_001274; EINECS 207-604-5; Geralen; SR-05000002173; KBio1_000529; KBioSS_001274; Majudin; 4-Methoxy-7H-furo[3,2-g]chromen-7-one #; 4-Methoxy-7H-furo[3,2-g]chromen-7-one; HMS501K11; 5-Methoxypsoralen, 99%; SMR000112435; NCGC00017357-03; NCGC00017357-07; CAS-484-20-8; B2840; AK134854; KS-00000GSD; TR-017690; Bergapten(e); NCGC00017357-04; BAS 00674110; CC-24574; C-11626; BERGAPTAN; Psoraderm; D07521; SDCCGMLS-0066492.P001; BRD-K12968785-001-03-4; MLS002207272; 5-Methoxypsoralen (Bergapten); InChI=1/C12H8O4/c1-14-12-7-2-3-11(13)16-10(7)6-9-8(12)4-5-15-9/h2-6H,1H; Bergaptene (DCF); 5-methoxy-psoralen; Pentaderm (TN); SPECTRUM300546; HY-N0370; ANW-42611; 5-Methoxypsoralen (obsol.); 5-Methoxy psoralen; KBioGR_002055; Oprea1_562364; Tox21_303255; NCGC00178705-02; Q-100536; Spectrum3_000663; BRD-K12968785-001-02-6; 4-methoxy-7H-furo[3,2-g][1]benzopyran-7-one; NCGC00017357-08; 7H-Furo[3,2-g][1]benzopyran-7-one, 4-methoxy-; ZINC57731; TNP00299; Bergapten; BDBM50067880; Spectrum5_000155; NSC755877; 4-Methoxy-7H-furo(3,2-g)(1)benzopyran-7-one; AB00052148_07; DS-2970; Spectrum_000794; KBio2_003842; 5-methoxy-2H-furo[3,2-g]chromen-2-one; BRN 0019560; NCGC00178705-01; 5-Mop; UNII-4FVK84C92X; M-9412; NCGC00091582-02; HMS2268M24; CHEBI:18293; CS-2234; 5 methoxypsoralen; 5-methoxypsoralen ; 5-Methoxy-6,7-furanocoumarin; KBio2_006410; NCGC00017357-05; SR-05000002173-5; CCG-39946; 5-Methoxypsoralen with ultraviolet A therapy; DSSTox_CID_5560; NSC95437; CJ-00484; 7H-Furo(3,2-g)(1)benzopyran-7-one, 4-methoxy-; ST057259; 6-Hydroxy-4-methoxy-5-benzofuranacrylic acid, .gamma.-lactone; NCGC00017357-02; N1304; AC1Q47BC; NCGC00091582-03; SBI-0051583.P002; 4-Methoxy-7H-furo[3,2-g]benzopyran-7-one; NSC 95437; 5-methoxyfurano[3,2-g]chromen-2-one; bergaptene; 484-20-8; CTK3J2399; s4239; Spectrum2_000534; Pentaderm; 4FVK84C92X; KBio3_001545; HMS3652F19; ST2411501; NINDS_000529; STK333038; MCULE-7768334865; NCGC00017357-06; HSDB 3466; 5-Methoxypsoralen; BSPBio_002325; CB-1199; 6-Hydroxy-4-methoxy-5-benzofuranacrylic acid, gamma-lactone; BGEBZHIAGXMEMV-UHFFFAOYSA-N; I14-13388; MFCD00010272; bmse000758; IDI1_000529; AB0019675; DB12216; 4-Methoxyfuro[3,2-g]benzopyrane-7-one; 4-Methoxyfuro[3,2-g]benzopyran-7-one; O-Methylbergaptol; 484B208; RTR-017690; NCGC00091582-04; SC-46077; AKOS000276715; SR-05000002173-3; CCRIS 4348; DSSTox_GSID_25560; 4-methoxyfuro[3,2-g]chromen-7-one; ZB002242; DTXSID1025560; NSC-755877; NCGC00091582-01; 5-methoxypsoralene; AX8014410; A827532; AJ-09777; ACon0_000984; Tox21_202357; HMS1923G13; FT-0603416; MEGxp0_000990; AC1L1DHU; MolPort-000-880-879; NSC-95437; 4CN-0945; NCI60_042121; BG01521510; 4-Methoxy-furo[3,2-g]chromen-7-one; NCGC00256998-01; AC-20189; CHEMBL24171; SPBio_000547; ACon1_001979; DSSTox_RID_77830; 7H-Furo[3, 4-methoxy-; SR-05000002173-2; Bergapten, analytical standard; SCHEMBL50066; 4-methoxy-7-furo[3,2-g][1]benzopyranone; Heraclin; C01557; Bio-0829; Spectrum4_001478; LS-1292; D0QR5G; Pharmakon1600-00300546; 5-Methoxyfuranocoumarin; MLS002454380; NCGC00017357-01; AN-9448	C12H8O4	216.19 g/mol	COC1=C2C=CC(=O)OC2=CC3=C1C=CO3
TCMBANKIN061871	gamma-fagarine	gamma-fagarine;Oprea1_872079; CCRIS 1584; Oprea1_404574; BRN 0212820; 8-Methoxydictamine; MLS001048993; MLS000532362; fagarine; Furo[2,3-b]quinoline, 4,8-dimethoxy-; C10676; .gamma.-Fagarine; 4,8-dimethoxyfuro[2,3-b]quinoline; ZINC00199415; SMR000137321; ST077119; gamma-Fagarine; Furo(2,3-b)quinoline, 4,8-dimethoxy-; AIDS342574; 4-27-00-02211 (Beilstein Handbook Reference); 524-15-2; CBDivE_012859; AIDS-342574;γ-fagarine;Fagarine	C13H11NO3	229.23 g/mol	COC1=CC=CC2=C1N=C3C(=C2OC)C=CO3
TCMBANKIN061915	3-dimethylallyl-4-methoxy-2-quinolone	3,3-dimethylallyl-4-methoxy-2-quinolone;2-(nonan-8-one)-(1h)-4-quinolone	C18H23NO2		COC1C2=CC=CC=C2NC(=O)C1(CCC=C)CCC=C

植物对应的疾病

疾病ID	病名	疾病类型	MeSH	参考文献

植物对应的靶点

靶点ID	基因名	基因别名	描述	染色体位置	Map_Location	基因类型

TCMBank_ID:

TCMBANKHE008047

ID:

TCMBANKHE008047

植物拉丁名:

Ruta graveolens

功能与主治:

To dispel wind, abate fever, disinhibit urine, quicken blood, resolve toxin, disperse swelling./Common cold with fever, wind-damp bone pain, infant fright wind, inhibited urination, diarrhea, mounting qi, amenorrhea, knocks and falls, heat toxin sores, eczema.

药用植物名:

臭草

药用部位:

whole herb

TCM_ID_id:

3321